Sort
34,240 grants matching “atherosclerosis”
Methods for determination of glycoprotein glycosylation similarities among disease states
$420,750Joseph Zaia · Boston University Medical Campus · R01 · FY2019 · GM
Methods for determination of glycoprotein glycosylation similarities among disease states
$420,750Joseph Zaia · Boston University Medical Campus · R01 · FY2020 · GM
Metabolic complications of HIV disease caused by Nef released from HIV-infected cells
$420,750Michael Ilya Bukrinsky · George Washington University · R01 · FY2016 · HL
Targeting microRNA-33 to reduce intracranial atherosclerosis and other neurovascular hallmarks of vascular cognitive impairment and dementia
$420,750Ryan Eugene Temel · University Of Kentucky · R21 · FY2019 · NS
Sphingolipid Signaling in Endothelial Responses to Injury
$420,750Teresa Sanchez Garcia-Vao · Beth Israel Deaconess Medical Center · R01 · FY2012 · HL
Methods for determination of glycoprotein glycosylation similarities among disease states
$420,750Joseph Zaia · Boston University Medical Campus · R01 · FY2021 · GM
DISTINCT HUMAN MACROPHAGE RECEPTOR FOR ABNORMAL VLDL
$420,720University Of Alabama At Birmingham · R01 · FY2001 · HL
SCAVANGER RECEPTOR-LIGAND BINDING AND PATHOPHYSIOLOGY
$420,699Massachusetts Institute Of Technology · R01 · FY2003 · HL
MESA
$420,697Russell P Tracy · University Of Vermont & St Agric College · N01 · FY2012 · HL
Role of Carboxylesterases in Innate Immunity
$420,691Matthew K Ross · Mississippi State University · R15 · FY2018 · GM
Crosstalk between CES1 and PPAR gamma and LXR alpha in macrophages
$420,691Matthew K Ross · Mississippi State University · R15 · FY2022 · HL
Lp-PLA2 and Coronary Atherosclerosis in Humans
$420,635Amir Lerman · Mayo Clinic Rochester · R01 · FY2009 · HL
Triglyceride Synthesis and Lipotoxicity
$420,635J. David Gladstone Institutes · R01 · FY2005 · DK
Cis-regulatory architecture of coronary vascular wall loci
$420,633Clint L Miller · University Of Virginia · R01 · FY2019 · HL
Mitochondrial Modulation of Endothelia Function
$420,594John Francis Keaney · Univ Of Massachusetts Med Sch Worcester · R01 · FY2015 · HL
Siglec-targeted nanoparticles for lung and cardiovascular disease
$420,505James C. Paulson · Johns Hopkins University · P01 · FY2013 · HL
KLF10, CD4+ T cells, and transplant arteriopathy
$420,500Mark W Feinberg · Brigham And Women'S Hospital · R01 · FY2017 · HL
KLF10, CD4+ T cells, and transplant arteriopathy
$420,500Mark W Feinberg · Brigham And Women'S Hospital · R01 · FY2019 · HL
KLF10, CD4+ T cells, and transplant arteriopathy
$420,500Mark W Feinberg · Brigham And Women'S Hospital · R01 · FY2020 · HL
Role of a novel IL18 binding protein in atherosclerosis
$420,500Guo-Ping Shi · Brigham And Women'S Hospital · R01 · FY2016 · HL
Role of a novel IL18 binding protein in atherosclerosis
$420,500Guo-Ping Shi · Brigham And Women'S Hospital · R01 · FY2018 · HL
Role of a novel IL18 binding protein in atherosclerosis
$420,500Guo-Ping Shi · Brigham And Women'S Hospital · R01 · FY2017 · HL
Novel imaging and treatment technologies for image-guided noninvasive stereotactic cardiac radiosurgery
$420,493H Michael Gach · Washington University · R01 · FY2021 · HL
Gene-Environment Interactions and Stroke Susceptibility
$420,472University Of Texas Hlth Sci Ctr Houston · R01 · FY2003 · HL
MYOCARDIAL PERFUSION, RISK FACTORS, AND CORONARY CALCIUM
$420,452University Of Minnesota Twin Cities · R01 · FY2000 · HL